SCHEMBL14486451

SCHEMBL14486451

COc1c(C)cc(-c2nc3c(O)nc(Cc4ccc(Cl)cc4)nc3o2)cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
ERCC1 P07992 1/20 0.37
ERCC4 Q92889 1/20 0.37
ALOX5 P09917 2/20 0.36
MAPK1 P28482 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
S1PR1 P21453 1/20 0.35
EGLN1 Q9GZT9 1/20 0.34
MAPT P10636 3/20 0.34
TSHR P16473 3/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
THRB P10828 1/20 0.34
KDR P35968 1/20 0.33
ALOX15 P16050 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14486566 0.89 ALDH1A1 (0.41) KDM4EALDH1A1HPGDERCC1ERCC4
SCHEMBL14486894 0.86 ALDH1A1 (0.39) KDM4EALDH1A1HPGDERCC1ERCC4
SCHEMBL14486411 0.84 ALDH1A1 (0.37) KDM4EALDH1A1HPGDERCC1ERCC4
SCHEMBL1832226 0.83 MAPK1 (0.38) KDM4EALDH1A1HPGDERCC1ERCC4
SCHEMBL14486815 0.77 ERCC1 (0.37) KDM4EALDH1A1HPGDERCC1ERCC4
SCHEMBL14552900 0.77 S1PR1 (0.47) KDM4EALDH1A1HPGDS1PR1EGLN1
SCHEMBL1829171 0.76 ALOX5 (0.36) KDM4EALDH1A1HPGDERCC1ERCC4
SCHEMBL1829903 0.76 DHPS (0.34) KDM4EALDH1A1HPGDERCC1ERCC4
SCHEMBL14486747 0.76 ERCC1 (0.36) KDM4EALDH1A1HPGDERCC1ERCC4
SCHEMBL1829092 0.75 S1PR1 (0.46) KDM4EALDH1A1ALOX5MAPK1S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9321787-B2 Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring SANOFI (FR) 2016-04-26 US disclosed
US-9321787-B2 Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring SANOFI (FR) 2016-04-26 US disclosed
US-9321787-B2 Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring SANOFI (FR) 2016-04-26 US disclosed
EP-2729471-B1 CARBOXYLIC ACID DERIVATIVES WITH AN OXAZOLO[5,4-D]PYRIMIDINE RING SANOFI SA (FR) 2015-05-06 EP disclosed
EP-2729471-A1 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-D]PYRIDINE RING SANOFI (FR) 2014-05-14 EP disclosed
US-20130023544-A1 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-d]PYRIMIDINE RING SANOFI (FR) 2013-01-24 US disclosed
US-20130023544-A1 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-d]PYRIMIDINE RING SANOFI (FR) 2013-01-24 US disclosed
US-20130023544-A1 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-d]PYRIMIDINE RING SANOFI (FR) 2013-01-24 US disclosed
WO-2013004827-A1 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-D]PYRIDINE RING SANOFI (FR) 2013-01-10 WO disclosed
WO-2013004827-A1 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-D]PYRIDINE RING SANOFI (FR) 2013-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130023544-A1 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-d]PYRIMIDINE RING OXGR1, CXCR1, DPYD KDM4E 1559/4885ALDH1A1 33/4885HPGD 265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.